BioAXOS SIGNED

Project "BioAXOS" data sheet

The following table provides information about the project.

 Partnership

Take a look of project's partnership.

Map

 Project objective

Prebiotics (just like other fibres) are carbohydrates—humans do not digest them, but probiotic bacteria in our gastrointestinal tracts flourish on them, making it more difficult for dangerous pathogenic bacteria to multiply. Prebiotics occur naturally in many fruits & vegetables—in chicory roots, avocados, peas, dandelion greens, as well as in whole & sprouted grains. There is a growing body of clinical studies & other scientifical evidence attesting to their positive effect on our health. At the moment the most widely used prebiotic is inulin (40% market share). More efficient recent prebiotics, XOS and more recently AXOS have attracted a lot of attention , since they substantially improves on other characteristics of other types of prebiotics. We have developed BioAXOS—a novel effective prebiotic from XOS family that fulfils the described criteria can replace inulin in at least half of its applications, taking a market share of at least 20%. In the EU only this represents a total addressable market of €200m. This process can be run on any bioethanol production plant (or grain milling facility) enabling additional revenue streams for them. As a result of our Phase 1 feasibility study we have secured a strategic partnership with Pannonia Ethanol to produce BioAXOS, which will accelerate our time to market by 2 years. With BioAXOS we are targeting at least 10% of the total prebiotics market by 2027, and at least 40% in the longer term. In this Phase 2 project we are requesting a €1.9m contribution to industrialize the BioAXOS process, undergo necessary regulatory approval to be able to sell into human food applications, as well as carry out 3 trials with functional food producers.